FOSTER CITY, Calif. & COPENHAGEN, Denmark, 06 May 2015 - Gilead Sciences, Inc. (NASDAQ:GILD) and EpiTherapeutics ApS, a privately-held Danish company, announced the signing of a definitive agreement pursuant to which Gilead has acquired EpiTherapeutics for $65 million.
